|
|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulation and VEGF ExpressionDepartment of Pharmacology (W.-L.Y., D.-Y.L., H.-C.L., W.-M.F.) and Graduate Institute of Pharmaceutical Science (C.-J.L.), College of Medicine, National Taiwan University, Taipei, Taiwan
Cerebral microvascular endothelial cells form the anatomical basis of the blood-brain barrier (BBB), and the tight junctions of the BBB are critical for maintaining brain homeostasis and low permeability. Ischemia/reperfusion is known to damage the tight junctions of BBB and lead to permeability changes. Here we investigated the protective role of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1), against chemical hypoxia and hypoxia/reoxygenation (H/R)-induced BBB hyperpermeability using adult rat brain endothelial cell culture (ARBEC). YC-1 significantly decreased CoCl2- and H/R-induced hyperpermeability of fluorescein isothiocyanate (FITC)-dextran in cell culture inserts. It was found that the decrease and disorganization of tight junction protein zonular occludens-1 (ZO-1) in response to CoCl2, and H/R was antagonized by YC-1. The protection of YC-1 may result from the inhibition of HIF-1
accumulation and production of its downstream target vascular endothelial growth factor (VEGF). VEGF alone significantly increased FITC-dextran permeability and down-regulated mRNA and protein levels of ZO-1 in ARBECs. We further used animal model to examine the effect of YC-1 on BBB permeability after cerebral ischemia/reperfusion. It was found that YC-1 significantly protected the BBB against ischemia/reperfusion-induced injury. Taken together, these results indicate that YC-1 may inhibit HIF-1
accumulation and VEGF production, which in turn protect BBB from injury caused by hypoxia.
Received for publication March 27, 2007.
Accepted for publication May 18, 2007.
Address correspondence to: Wen-Mei Fu, Department of pharmacology, College of Medicine, National Taiwan University, 1, Sec. 1, Jen-Ai Road, Taipei, Taiwan., E-mail: wenmei{at}ntu.edu.tw
This article has been cited by other articles:
![]() |
L. Mahimainathan, N. Ghosh-Choudhury, B. Venkatesan, F. Das, C. C. Mandal, N. Dey, S. L. Habib, B. S. Kasinath, H. E. Abboud, and G. Ghosh Choudhury TSC2 Deficiency Increases PTEN via HIF1{alpha} J. Biol. Chem., October 9, 2009; 284(41): 27790 - 27798. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. R. Mwaikambo, C. Yang, S. Chemtob, and P. Hardy Hypoxia Up-regulates CD36 Expression and Function via Hypoxia-inducible Factor-1- and Phosphatidylinositol 3-Kinase-dependent Mechanisms J. Biol. Chem., September 25, 2009; 284(39): 26695 - 26707. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-L. Yeh, C.-J. Lin, and W.-M. Fu Enhancement of Glucose Transporter Expression of Brain Endothelial Cells by Vascular Endothelial Growth Factor Derived from Glioma Exposed to Hypoxia Mol. Pharmacol., January 1, 2008; 73(1): 170 - 177. [Abstract] [Full Text] [PDF] |
||||